Table 4 Effect of PA on MI or stroke among female participants stratified by age (OR (95%CI)).
Age | ||||
|---|---|---|---|---|
< 45 | 45–59 | 60–74 | 75– | |
MI | ||||
MPA* | – | 0.534 (0.140–2.041) | 0.265 (0.134–0.527)** | 0.856 (0.253–2.902) |
VPA* | – | 0.268 (0.077–0.933)** | 0.257 (0.143–0.464)** | 1.042 (0.333–3.262) |
Stroke | ||||
MPA* | – | 1.669 (0.497–5.611) | 0.467 (0.309–0.705)** | 0.378 (0.182–0.783)** |
VPA* | – | 1.459 (0.455–4.675) | 0.321 (0.219–0.471)** | 0.415 (0.213–0.810)** |
MS | ||||
MPA* | – | 1.102 (0.452–2.683) | 0.154 (0.126–0.187)** | 0.449 (0.234–0.862)** |
VPA* | – | 0.847 (0.365–1.966) | 0.108 (0.095–0.123)** | 0.545 (0.301–0.986)** |